AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc. 0.11%82.360.7%$1556.69m
JNJJohnson & Johnson -0.04%165.700.7%$1044.17m
PFEPfizer Inc. 0.37%43.700.9%$945.42m
ABBVAbbVie, Inc. -0.08%109.321.9%$659.34m
LLYEli Lilly & Co. 0.43%249.551.1%$641.87m
BMYBristol-Myers Squibb Co. -0.16%58.121.0%$633.95m
AZNAstraZeneca Plc 0.11%62.331.0%$285.30m
NVSNovartis AG -1.85%83.260.2%$179.31m
GSKGlaxoSmithKline Plc -0.92%39.790.2%$163.74m
AVIRAtea Pharmaceuticals, Inc. 0.00%12.390.3%$123.47m
RGENRepligen Corp. 0.00%273.836.8%$109.24m
VTRSViatris, Inc. 0.30%13.520.0%$89.79m
NVONovo Nordisk A/S -1.31%105.970.1%$89.66m
SNYSanofi -1.10%49.410.2%$65.71m
OGNOrganon & Co. -0.33%36.620.0%$52.99m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.